Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects
December 01, 2023 at 07:35 AM EST
Pfizer's drug helped patients lose weight but also caused nausea and diarrhea.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|